Whereas in normal prostate cells, androgens drive anabolic lipid metabolism to support the secretory function of the prostate gland, the dysregulated lipid metabolism associated with aberrant AR signaling in prostate cancer contributes to proliferation, disease progression, and the development treatment resistance (reviewed in ref. 44). The gene discussed is AR; the disease is prostate cancer.